EXHIBIT 1
---------
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as
amended, each of the persons named below agrees to the joint filing of a
Statement on Schedule 13D (including amendments thereto) with respect to the
common stock, par value $0.001 per share, of Idenix Pharmaceuticals, Inc., a
Delaware corporation.
Date: November 2, 2005
NOVARTIS AG
By: /s/ Xxxxx Xxxxxxxxx
--------------------------------
Name: Xxxxx Xxxxxxxxx
Title: Authorized Signatory
By: /s/ Xxxxxx Xxxxxxxxxxxx
--------------------------------
Name: Xxxxxx Xxxxxxxxxxxx
Title: Authorized Signatory
NOVARTIS PHARMA AG
By: /s/ Xxxxxxxx Xxxxx
--------------------------------
Name: Xxxxxxxx Xxxxx
Title: Head of Legal Ophtha and
Oncology Europe
By: /s/ Xxxxxx Xxxxx
--------------------------------
Name: Xxxxxx Xxxxx
Title: Head Operational Treasury
Page 10 of 10